Novome Biotechnologies
Novome is building genetically engineered microbial medicines (GEMMs) that perform defined activities in the human gut to treat chronic diseases. We have developed the first platform for controlled colonization of the gut with engineered therapeutic bacteria, and are applying this to multiple disease areas as well as expanding our platform capabilities. Our lead program in enteric hyperoxaluria is currently in Phase 2 clinical trials, and we are focusing current research efforts on making a microbial cell therapy to treat inflammatory bowel disease (IBD).
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
1
11 to 50 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
105
organic / mo
Sign up free to see all 4 verified contacts at Novome Biotechnologies
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- DF
Dean Falb
Scientific Advisory Board Member · Science
EmailPhone - AL
Alexander Louie
Scientist · Research & Development
EmailPhone - JG
Janeth Godoy
Senior Research Associate · Research & Development
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Novome Biotechnologies
4 distinct titles indexed · top 4 shown.
- 1scientific advisory board member
- 1scientist
- 1senior research associate
- 1senior scientist
Sign up to unlock all 4 contacts at Novome Biotechnologies
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Novome Biotechnologies
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.